KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Research & Development (2016 - 2026)

Globus Medical filings provide 15 years of Research & Development readings, the most recent being $36.2 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 8.25% to $36.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $147.2 million, a 23.65% increase, with the full-year FY2025 number at $147.2 million, down 10.08% from a year prior.
  • Research & Development hit $36.2 million in Q4 2025 for Globus Medical, down from $38.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $52.3 million in Q4 2023 to a low of $12.6 million in Q1 2024.
  • Median Research & Development over the past 5 years was $25.3 million (2023), compared with a mean of $28.0 million.
  • Biggest five-year swings in Research & Development: soared 234.77% in 2021 and later plummeted 61.77% in 2022.
  • Globus Medical's Research & Development stood at $51.0 million in 2021, then plummeted by 61.77% to $19.5 million in 2022, then skyrocketed by 167.86% to $52.3 million in 2023, then crashed by 36.06% to $33.4 million in 2024, then rose by 8.25% to $36.2 million in 2025.
  • The last three reported values for Research & Development were $36.2 million (Q4 2025), $38.1 million (Q3 2025), and $40.0 million (Q2 2025) per Business Quant data.